Clinical and Epidemiologic Characteristics of Infants Hospitalized with Respiratory Syncytial Virus Infection During the 2022-2023 Season in Mexico.

Authors :: Esparza-Miranda LA
Juárez-Tobías S
Muñoz-Escalante JC
Oliva-Jara UA
Cadena-Mota S
Wong-Chew RM
Noyola DE
Source :: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2023 Oct 01; Vol. 42 (10), pp. e382-e384. Date of Electronic Publication: 2023 Jun 22.
Publication Year :: 2023
Abstract: In 2022, several countries reported an increase in respiratory syncytial virus (RSV) infections. We assessed the clinical characteristics and outcomes of infants hospitalized with RSV and compared them with infants hospitalized between 2009 and 2015. No significant differences in underlying disorders, intensive care unit admission rates and mortality were observed suggesting currently circulating RSV strains do not show heightened virulence.<br />Competing Interests: D.E.N. has participated as a member of the speakers’ bureau of AbbVie and Astra-Zeneca, speakers’ bureau and advisory board for Sanofi Pasteur and advisory board for Pfizer. R.M.W.-C. has participated as a member of advisory board for Sanofi Pasteur. The other authors have no conflicts of interest to disclose.<br /> (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)

Subjects :: Infant
Humans
Hospitalization
Mexico epidemiology
Seasons
Respiratory Syncytial Virus Infections epidemiology
Respiratory Syncytial Virus, Human

Full Text Access

Tools